Divi’s Labs Q3 Results: Profit Slips to ₹583 Crore, Income Climbs 12% in Q3FY26 | Stock Market Today

Divi's Labs Q3 Results are out. And the numbers tell a mixed but steady story.

For the quarter ended December 31, 2025 (Q3FY26), Divi’s Laboratories reported a marginal dip in net profit. At the same time, income continued to grow at a healthy pace.

The market reaction stayed positive. Investors focused on the growth in income and stronger nine-month performance rather than the slight quarterly profit decline.

Let’s break down the Divi's Labs Q3 Results in detail.

Market Performance

After the announcement of Divi's Labs Q3 Results, the stock was trading in the green.

• Share price: ₹6,303.20 on BSE
• Gain: Over 2%

The positive move signals that the market absorbed the marginal dip in Q3 profit and looked at the broader numbers.

Divi's Labs Q3 Results: What Happened in Q3FY26?

Divi’s Laboratories announced its results after the Board meeting held on February 11, 2026.

The headline numbers from Divi's Labs Q3 Results show steady revenue growth but softer profit momentum.

Consolidated Performance – Q3FY26

• Profit After Tax (PAT): ₹583 crore
  (vs ₹589 crore in Q3FY25)
• Total Income: ₹2,692 crore
  (vs ₹2,401 crore in Q3FY25)

That means:

• Net profit fell marginally by ₹6 crore year-on-year.
• Total income increased by ₹291 crore.
• Income growth stood at 12.11% YoY.

The profit decline is minor. The income growth is clearly stronger. That contrast defines Divi's Labs Q3 Results this quarter.

Exceptional Item Impacted Q3 Numbers

One key detail in Divi's Labs Q3 Results was the exceptional item.

• Exceptional loss: ₹74 crore
• Reason: Impact of new labour codes

This adjustment influenced the consolidated profit for the quarter. Without this charge, profit comparison would look different. But the reported number stands at ₹583 crore.

This is important context while reading Divi's Labs Q3 Results.

Standalone Performance – December Quarter

On a standalone basis, operations remained stable.

Revenue from Operations

• ₹2,578 crore in Q3FY26
• Growth: 12.2% YoY

Revenue growth stayed aligned with consolidated trends.

Standalone Net Profit

• ₹598 crore in Q3FY26
• ₹594 crore in Q3FY25
• Growth: 0.7% YoY

Profit growth here was muted. Revenue expanded strongly. But earnings moved only slightly.

This again reflects the theme seen in Divi's Labs Q3 Results — healthy top line, limited profit expansion for the quarter.

Nine-Month Performance (9M FY26): The Bigger Picture

While quarterly numbers were steady, the nine-month data in Divi's Labs Q3 Results looks stronger.

For the nine months concluded on December 31, 2025:

Consolidated Performance – 9M FY26

• Total Income: ₹8,081 crore
  Growth: 14.8% YoY
• Consolidated PAT: ₹1,817 crore
  Growth: 18.8% YoY

This is where momentum becomes visible.

Income growth crossed 14%. Profit growth was even higher at 18.8%. That suggests improved operating leverage over the longer period.

The nine-month stretch paints a firmer picture than the single December quarter.

Standalone Performance – 9M FY26

Standalone data also reflected stronger earnings momentum.

• Revenue Growth: 14.0% YoY
• Standalone PAT: ₹1,851 crore
• PAT Growth: 20.0% YoY

Twenty percent profit growth over nine months is significant. Especially when compared to the modest 0.7% increase seen in the December quarter alone.

This shows that Divi's Labs Q3 Results are not weak — they are quarter-specific in softness, but stronger in longer duration performance.

Financial Snapshot from Divi's Labs Q3 Results

Q3FY26 (Consolidated)

• Total Income: ₹2,692 crore
• PAT: ₹583 crore
• Exceptional Loss: ₹74 crore

Q3FY26 (Standalone)

• Revenue: ₹2,578 crore
• PAT: ₹598 crore

9M FY26 (Consolidated)

• Total Income: ₹8,081 crore
• PAT: ₹1,817 crore

9M FY26 (Standalone)

• Revenue Growth: 14.0% YoY
• PAT: ₹1,851 crore
• PAT Growth: 20.0% YoY

What the Numbers Indicate?

The story of Divi's Labs Q3 Results is simple.

• Income growth remains strong at over 12% in Q3.
• Nine-month income growth stands close to 15%.
• Quarterly profit dipped marginally.
• Nine-month profit rose nearly 19–20%.
• A ₹74 crore exceptional charge affected reported Q3 profit.

Short term — profit slowed.

Long term — performance improved meaningfully.

The data speaks clearly.

Company Overview: Divi’s Laboratories

Divi’s Laboratories operates in the pharmaceutical manufacturing segment. The company reports both consolidated and standalone financials.

In Divi's Labs Q3 Results, the company showed consistency in revenue growth while managing profitability through varying cost conditions.

The quarterly softness does not override the broader nine-month expansion reflected in income and profit numbers.

Summary of Divi's Labs Q3 Results

Divi's Labs Q3 Results for Q3FY26 reflect a stable business with moderate quarterly profit pressure.

• Consolidated net profit: ₹583 crore
• Total income: ₹2,692 crore
• Income growth: 12.11% YoY
• Exceptional loss: ₹74 crore
• Nine-month PAT growth: 18.8% YoY

The December quarter was steady but not explosive. The nine-month trend was stronger.

In the end, Divi's Labs Q3 Results show growing income, disciplined operations, and stable long-term earnings momentum — even with a mild quarterly dip in profit.

No noise. Just numbers.

Source: Livemint